title: [Invasive aspergillosis: treatment].
abstract: Invasive aspergillosis is a severe disease, affecting essentially congenital or acquired immunodepressed patients, as well as neutropenic or transplanted ones, and those undergoing prolonged chemotherapy or treatment with corticoids. At present, the physician only disposes of the following treatment: amphotericin B desoxycolate, lipidic amphotericins and itraconazole p.o. or intravenously. Very soon, other drugs like voriconazole, posaconazole, liposomal nystatin and echinocandins probably will have a role in the treatment. It is most important to know thoroughly the patients's base disease and its specific treatment and the role of the drugs at present available, their relevant dosage, biodisponibility and pharmacokinetics, as well as adverse effects and evidence-based criterions of application. It is very important indeed to maintain a high suspicion of the disease and a rapid start of treatment. It is equally important to assess the role of coadjuvant treatments. We insist in the importance of surgery in solving of the disease in some cases (progressive pulmonar aspergillosis, sinusitis) combined with appropriate antifungal treatment.
authors.affiliation: Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, España. 12822@imas.imim.es
authors.forename: P
authors.initials: P
authors.lastname: Saballs-Radresa
authors.forename: J L
authors.initials: JL
authors.lastname: López-Colomés
authors.forename: J
authors.initials: J
authors.lastname: Gimeno-Cobos
authors.forename: H
authors.initials: H
authors.lastname: Knobel